Private equity fund Blackstone is set to submit a non-binding bid as early as next week to acquire the entire 33.47% promoter stake in Cipla, India’s third-largest generics company by revenues, The Economic Times reported on Friday.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
